<p><strong>Hepatic Impairment</strong>: In patients with hepatic impairment, blood levels of may be increased. Therefore the dose of Deflazacort should be carefully monitored and adjusted to the minimum effective dose.<br />
<br />
<strong>Renal Impairment</strong>: In renally impaired patients, no special precautions other than those usually adopted in patients receiving glucocorticoid therapy are necessary.<br />
<br />
<strong>Elderly</strong>: In elderly patients, no special precautions other than those usually adopted in patients receiving glucocorticoid therapy are necessary. The common adverse effects of systemic corticosteroids may be associated with more serious consequences in old age.</p>